- Sales Analytics
-
Sales Reporting and Activity Dashboards - Sales Force Sizing and Structuring
- Territory Alignment
- Incentive Compensation Administration Dashboards
- Forecasting
- Data analytics
- KAM tools
- Competitive Intelligence, Primary and Secondary Research
- Scientific Competitive Intelligence
- Market Research
- -Primary Market Research
- -Secondary Market Research
- Business Development and Licensing
- KOL ( Key Opinion Leader ) Mining
- India Market Entry Strategy
- Systematic Literature Review
- Systematic Literature Review
India Market Entry Strategy
India is one of the world's most attractive emerging markets for bio-pharmaceuticals and healthcare in general : the macro-economic fundamentals of high economic growth, rise in purchasing power combined with a new Intellectual property regime that allows bio-pharma innovations to be patented and a changing payor landscape with the emergence of health care insurance.
However India presents some unique and complex challenges. To list a few:
- India is a highly genericized market - with branded generics dominating over 90% of the market. Hence bio-pharmaceuticals will find that there are generic substitutes of seemingly substitutable drug classes
- Patient algorithms in India are different and may not follow the "global" algorithm
- India's IP law has a section that requires innovators to prove their IP is an innovation that has a medical benefit
Our offerings include developing a forecast for client's current marketed portfolio and their pipeline, developing an India "road map" and entry strategy and working through the next level of questions linked to the execution of an India entry : choice of the business model, identifying and recommending potential distribution partners, supply chain model and execution.
The Challenge
A mid sized UK specialty pharma company was looking to enter India for a wound care product in the diabetes wound care market. The client was particularly focused on the "execution piece" - looking for partners/distributors that would be willing to invest sales and marketing dollars in their brand and have a good portfolio fit.
The Solution
Value Edge provided the client with a market and competitive landscape using a combination of secondary and primary data. We conducted due-diligence on a number of mid sized Indian pharmaceutical companies to assess and identify a good "strategic fit" and a "portfolio fit". After shortlisting partners, we had preliminary meetings with each of them and presented the shortlisted partners to our client. Finally we coordinated an India visit, and prioritized 2 partners for the client. Currently the client is working with the short-listed Indian company.
Asia
New Delhi, India
email: info@valuedgeindia.com
Europe
Paris, France
email: info@valuedgeindia.com
North America
Boston
email: info@valuedgeindia.com